The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Cologuard has gained popularity since its approval in 2014. The FDA approval was granted in part to improve rates of colon cancer screening, which prior to Cologuard’s release stood at 65%.

Then, a few months ago, Meaney was watching "Squawk Box," a morning news and talk show, when he heard about Cologuard, an at-home, stool-based test for colorectal cancer, which the Food and Drug ...

Cologuard is easy for patients to use and easy for doctors to interpret the results, said Dr. Casey Allen, a surgical oncologist at Allegheny Health Network in Pennsylvania.

There are two reasons that I think the Cologuard is still a reasonable choice, despite the fact that it isn’t as good as colonoscopy. The first is that I continue to recommend a screening test for ...

A 2013 trial of the first iteration of Cologuard, known as DeeP-C, showed the test is 92% sensitive and 87% specific. Put differently, Cologuard returned false positive results 13% of the time in ...

The Cologuard cancer screening test developed by Exact Sciences Corp. of Madison has won the highly regarded Prix Galien USA award for medical technology, Exact Sciences said Friday.

Here, two gastroenterologists share their thoughts on Cologuard: Harish Gagneja, MD, gastroenterologist at Austin (Texas) Gastroenterology: I don’t recommend Cologuard as a first-line test because: ...

Unlock URL Order Reprints Gift this Article An image from Cologuard's television ad By Teddy Nykiel – Reporter, Milwaukee Business Journal Mar 2, 2022 Updated Mar 3, 2022 10:26am CST ...

Cologuard measures DNA methylation in two genes: NDRG4 and BMP3. Abnormal methylation of NDRG4 and BMP3, considered tumor suppressors, has been linked to colorectal tumors.